Shanna H Swan, PhD
About Me
Dr. Swan has worked for over twenty-five years to understand the threats posed by chemicals to our environment and our health, and, when necessary, to develop new paradigms to assess their risks. Of most concern to Dr. Swan are the chemicals that our bodies can confuse with its own hormones (the “endocrine disrupting” chemicals). At the Icahn School of Medicine at Mount Sinai, Department of Environmental Medicine and Public Health, Dr. Swan is working with a wide range of collaborators, including epidemiologists, biostatisticians, toxicologists, geneticists and systems biologists, to conduct studies and develop methods to evaluate the risks from such chemicals — methods that are sensitive enough to tease out the often subtle health effects of complex mixtures.
Language
Position
About Me
Dr. Swan has worked for over twenty-five years to understand the threats posed by chemicals to our environment and our health, and, when necessary, to develop new paradigms to assess their risks. Of most concern to Dr. Swan are the chemicals that our bodies can confuse with its own hormones (the “endocrine disrupting” chemicals). At the Icahn School of Medicine at Mount Sinai, Department of Environmental Medicine and Public Health, Dr. Swan is working with a wide range of collaborators, including epidemiologists, biostatisticians, toxicologists, geneticists and systems biologists, to conduct studies and develop methods to evaluate the risks from such chemicals — methods that are sensitive enough to tease out the often subtle health effects of complex mixtures.
Language
Position
Video
Locations
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Swan has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Swan has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.